Pyrosequencing Gets Patent, Approaches Clinical Diagnostics | GenomeWeb

NEW YORK, May 23 - Pyrosequencing on Wednesday took a step closer to entering the diagnostics market, announcing that it had received a patent for assessing cardiovascular conditions such as myocardial infarction and stroke.

“This is extraordinarily important – it establishes us as a player in diagnostics in the cardiovascular area,” Jerry Williamson, vice president of global diagnostics, told GenomeWeb.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.